Gustavo Monnerat: The Rejection Letter That Became a Nobel Prize
Gustavo Monnerat, Deputy Editor at The Lancet, shared a a post on LinkedIn:
“The Rejection Letter That Became a Nobel Prize, and What It Teaches Us
You’ve probably seen this letter before.
In 1992, Nature rejected Peter Ratcliffe’s paper
27 years later, he won the Nobel Prize for the same discovery.
This story if often used as a reminder to never lose faith.
And yes, perseverance matters a lot.
But there’s another lesson here:
Even the best ideas can be missed if they aren’t clearly written, contextualized, and supported by data that communicates their novelty and significance.
Editors and reviewers don’t reject ideas, they reject what they can’t fully see or understand.
And in a world where scientific output grows exponentially, clarity has become a key part of scientific impact.
5 Ways to Help Editors and Reviewers See the Value of Your Work
- Novelty & Significance
Make the advance explicit: what’s new, why it matters, and how it moves the field forward. - Rigor & Transparency
Explain your methods so readers can trust and reproduce them. Clarity equals credibility. - Results & Data Storytelling
Let figures speak. Highlight the key contrast or effect in seconds, reviewers scan, not dig. - Interpretation & Implications
Go beyond results. Explain why the finding changes understanding or practice. - Integration & Next Steps
Situate your work in the broader scientific conversation, and show where it leads next.”
Stay updated with Hemostasis Today.
-
Nov 3, 2025, 08:23The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
-
Nov 3, 2025, 08:15Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
-
Nov 3, 2025, 07:10Lisa Shea Shares Key Takeaways from NORD Summit 2025
-
Nov 3, 2025, 06:49Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 3, 2025, 04:56Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 3, 2025, 09:24Stephen Cornelissen: It’s Not Just About Emergencies — It’s About Everyday Care, Chronic Conditions and Hope
-
Nov 3, 2025, 06:57Maria Elisa Mancuso Reflects on 2025 Annual Congress of the Italian Association of Hemophilia Centres
-
Nov 3, 2025, 05:46Chandra Viswanathan: When Blood Safety Fails, We All Bleed - A Call for Reform and Responsibility
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry